Exact Mass: 538.3634
Exact Mass Matches: 538.3634
Found 317 metabolites which its exact mass value is equals to given mass value 538.3634
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Methanophenazine
Fusidate Sodium
D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent Fusidic acid sodium salt (Sodium fusidate), a bacteriostatic antibiotic produced from the Fusidium coccineum fungus, belongs to the class of steroids. Fusidic acid sodium salt has no corticosteroid effects. Fusidic acid sodium salt inhibits the growth of bacteria by preventing the release of translation elongation factor G (EF-G) from the ribosome[1][2].
Octaethyleneglycol monododecyl ether
D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D013501 - Surface-Active Agents > D003902 - Detergents D001697 - Biomedical and Dental Materials
DG(8:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0)
DG(8:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-2OH(5,6)/8:0/0:0)
DG(20:3(8Z,11Z,14Z)-2OH(5,6)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-2OH(5,6)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:3(8Z,11Z,14Z)-2OH(5,6))
DG(8:0/0:0/20:3(8Z,11Z,14Z)-2OH(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-2OH(5,6)/0:0/8:0)
DG(20:3(8Z,11Z,14Z)-2OH(5,6)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labd-7-ene-2-O-beta-xylopyranoside
(20R,22R)-6-oxo-2beta,3beta,5,14alpha,20,25-hexahydroxy-5beta-cholest-7-en-22-yl acetate|polypodin B 22-acetate|polypodine B 22-acetate|polypodine B-22-O-acetate
3alpha-Methacryloyloxy-2beta,15-dihydroxy-ent-labd-7-ene-2-O-alpha-rhamnopyranoside
3-O-beta-D-glucopyranosyl-3beta,12beta-dihydroxy-22, 23, 24, 25, 26, 27-hexanordammarane-20-one|ginsenoside R10
16,24-dihydroxy-cycloarta-20,25-dien-3-one diacetate|Argentatin G|argentatin G diacetate
Phe Phe Ile Ile
Phe Phe Ile Leu
Phe Phe Leu Ile
Phe Phe Leu Leu
Phe Ile Phe Ile
Phe Ile Phe Leu
Phe Ile Ile Phe
Phe Ile Leu Phe
Phe Leu Phe Ile
Phe Leu Phe Leu
Phe Leu Ile Phe
Phe Leu Leu Phe
His Lys Arg Val
His Lys Val Arg
His Arg Lys Val
His Arg Val Lys
His Val Lys Arg
His Val Arg Lys
Ile Phe Phe Ile
Ile Phe Phe Leu
Ile Phe Ile Phe
Ile Phe Leu Phe
Ile Ile Phe Phe
Ile Leu Phe Phe
Lys His Arg Val
Lys His Val Arg
Lys Arg His Val
Lys Arg Val His
Lys Val His Arg
Lys Val Arg His
Leu Phe Phe Ile
Leu Phe Phe Leu
Leu Phe Ile Phe
Leu Phe Leu Phe
Leu Ile Phe Phe
Leu Leu Phe Phe
Arg His Lys Val
Arg His Val Lys
Arg Lys His Val
Arg Lys Val His
Arg Val His Lys
Arg Val Lys His
Val His Lys Arg
Val His Arg Lys
Val Lys His Arg
Val Lys Arg His
Val Arg His Lys
Val Arg Lys His
(2S)-3,3-Dimethyl-2-[[[[(1R,2R)-2-(2-methyl-5-phenyl-1H-pyrrol-1-yl)cyclohexyl]amino]thioxomethyl]amino]-N,N-bis(2-methylpropyl)butanamide
2-[(2-Acetyloxy-3-hexadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
O-(1-O-Palmitoyl-2-O-acetyl-L-glycero-3-phospho)choline
3alpha-[(beta-D-Glucopyranosyl)oxy]-5beta-cholanic acid
2-[hydroxy-[(2R)-2-hydroxy-3-nonadecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-hexadecoxy-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
N,N,N-Trimethyl-2-[[[(R)-2-acetyloxy-4-oxahenicosan-1-yloxy]phosphinato]oxy]ethanaminium
[O-(1-O-Acetyl-2-O-hexadecanoyl-L-glycero-3-phospho)choline]anion
2-[[(2R)-2-formyloxy-3-octadecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2R)-2-hydroxy-3-[8-[(2R,3S)-3-octyloxiran-2-yl]octanoyloxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2R)-3-hydroxy-2-[(Z)-12-hydroxyoctadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2R)-2-hydroxy-3-[8-[(2S,3R)-3-octyloxiran-2-yl]octanoyloxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-8-hydroxyoctadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-11-hydroxyoctadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
(Z)-4-[[3,3-dimethyl-2-[(2,4,4,9-tetramethyl-1,3-dihydropyrido[3,4-b]indole-3-carbonyl)amino]butanoyl]-methylamino]-2,5-dimethylhex-2-enoic acid
2,3-dihydroxypropyl [3-[(Z)-henicos-11-enoxy]-2-hydroxypropyl] hydrogen phosphate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-icos-11-enoate
[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
1,2-Dinonanoyl-sn-glycero-3-phosphocholine, 20 mg/mL in chloroform, ~99\\% (TLC)
2-[(3-Hexadecoxy-2-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(2-Acetyloxy-3-heptadecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(3-Acetyloxy-2-hexadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(2-Decanoyloxy-3-octanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
[3-hydroxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropyl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
2-[Hydroxy-(2-hydroxy-3-nonadecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(3-hydroxy-2-nonadecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
[1-carboxy-3-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(E)-dec-4-enoyl]oxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(E)-dec-4-enoyl]oxypropoxy]propyl]-trimethylazanium
2-[(3-Butanoyloxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
[3-[3-acetyloxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
[3-[3-butanoyloxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
2-[Hydroxy-(3-pentanoyloxy-2-tridecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(2-pentanoyloxy-3-tetradecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[(3-Heptanoyloxy-2-undecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(2-Dodecanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(2-pentadecanoyloxy-3-propanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2R)-1,1,2,3,3-pentadeuterio-2-hydroxy-3-nonadecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(3-octoxy-2-undecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[carboxy-[2-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
2-[(2-Butanoyloxy-3-pentadecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(2-Hexanoyloxy-3-tridecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(2-Decanoyloxy-3-nonoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(3-Dodecoxy-2-heptanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(3-Decoxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(2-octanoyloxy-3-undecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium
Dodecyl octaethylene glycol ether
D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D013501 - Surface-Active Agents > D003902 - Detergents D001697 - Biomedical and Dental Materials
1-(11Z-eicosenoyl)-glycero-3-phospho-(1-sn-glycerol)
methyl (6r)-6-[(1r,2s,3ar,5ar,9as,11ar)-2-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoate
1,3-oxazol-5-yl({4-[(1r,3s,4r,5s)-1,3,4,5-tetrahydroxyhexyl]-1,3-oxazol-2-yl})methyl 13-methyltetradecanoate
(2s)-2-{[(2s)-2-[bis(3-methylbut-2-en-1-yl)amino]-1-hydroxy-3-phenylpropylidene]amino}-3-methyl-n-[(1s)-2-methyl-1-(1,3-thiazol-2-yl)propyl]butanimidic acid
10-[7-(acetyloxy)-3a,6,6,9a-tetramethyl-2-oxo-octahydrocyclopenta[a]naphthalen-3-ylidene]-2,6-dimethylundeca-2,6,8-trien-5-yl acetate
3,3'-bis(6-isopropyl-3-methylcyclohex-2-en-1-yl)-5,5'-bis(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2'-diol
(1s)-4-[(2r,4ar,6r,8as)-6-[(2s,5s)-5-(2-methoxypropan-2-yl)-2-methyloxolan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pent-4-en-1-ol
(2r,3r)-2-[(1s,3as,5as,7r,8s,9ar,9br,11ar)-3a,5a,7,8-tetrahydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-dihydroxy-6-methylheptan-3-yl acetate
(1s,3br,6r,9ar,11as)-1-[1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-7-(n-methylbenzamido)-tetradecahydro-1h-cyclopenta[a]phenanthren-6-yl acetate
(2e)-3-[(1s,2s,4as,5r,6r,7r,8s,8ar)-5,6,7-trihydroxy-3,4a,8-trimethyl-2-[(2e,5r,7s,8r,9r)-5,7,9-trihydroxy-8,10-dimethylundec-2-en-2-yl]-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-2-methylprop-2-enoic acid
5-(5-hydroxy-3-methylpentyl)-1,1,4a,6-tetramethyl-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3,4,5,8,8a-hexahydronaphthalen-2-yl 2-methylbut-2-enoate
6-[(1s,3r,12s,14s,16r)-14-(acetyloxy)-7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-2-methylhepta-1,6-dien-3-yl acetate
(2e,4e,6e,8e,10e,12e,14e,16e,18e,20e,22e)-23-(4-hydroxy-2,3,3-trimethyl-6-oxocyclohex-1-en-1-yl)-4,8,12,17,21-pentamethyltricosa-2,4,6,8,10,12,14,16,18,20,22-undecaenal
1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4-[6-(5-isopropyl-5-methoxy-2-methyloxolan-2-yl)-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]pent-4-en-1-ol
(2s,3s,4as,5r,8as)-5-[(3s)-5-hydroxy-3-methylpentyl]-1,1,4a,6-tetramethyl-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalen-2-yl 2-methylprop-2-enoate
(2S,3S)-N-[(1S)-1-carbamoyl-3-methyl-butyl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-formylphenoxy)-4-methyl-valeramide
{"Ingredient_id": "HBIN006727","Ingredient_name": "(2S,3S)-N-[(1S)-1-carbamoyl-3-methyl-butyl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-formylphenoxy)-4-methyl-valeramide","Alias": "(2S,3S)-N-[(1S)-1-carbamoyl-3-methyl-butyl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-formylphenoxy)-4-methyl-pentanamide; (2S,3S)-N-[(2S)-1-amino-4-methyl-1-oxo-pentan-2-yl]-2-[[(2S)-2-dimethylamino-3-phenyl-propanoyl]amino]-3-(4-methanoylphenoxy)-4-methyl-pentanamide; (2S,3S)-N-[(1S)-1-carbamoyl-3-methylbutyl]-2-[[(2S)-2-dimethylamino-1-oxo-3-phenylpropyl]amino]-3-(4-formylphenoxy)-4-methylpentanamide; (2S,3S)-N-[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]-2-[[(2S)-2-dimethylamino-3-phenylpropanoyl]amino]-3-(4-formylphenoxy)-4-methylpentanamide","Ingredient_formula": "C30H42N4O5","Ingredient_Smile": "NA","Ingredient_weight": "538.68","OB_score": "15.65957604","CAS_id": "107494-21-3","SymMap_id": "SMIT03939","TCMID_id": "NA","TCMSP_id": "MOL001538","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}